1. Home
  2. KOSS vs ACET Comparison

KOSS vs ACET Comparison

Compare KOSS & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koss Corporation

KOSS

Koss Corporation

HOLD

Current Price

$4.00

Market Cap

39.3M

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$7.18

Market Cap

69.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOSS
ACET
Founded
1953
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
69.6M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
KOSS
ACET
Price
$4.00
$7.18
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$56.00
AVG Volume (30 Days)
17.8K
117.2K
Earning Date
04-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
10.00
N/A
EPS
N/A
N/A
Revenue
$12,624,170.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.93
N/A
52 Week Low
$3.90
$0.45
52 Week High
$8.59
$9.05

Technical Indicators

Market Signals
Indicator
KOSS
ACET
Relative Strength Index (RSI) 43.29 50.17
Support Level N/A $6.54
Resistance Level $5.04 $8.46
Average True Range (ATR) 0.12 0.46
MACD -0.01 -0.05
Stochastic Oscillator 33.78 37.24

Price Performance

Historical Comparison
KOSS
ACET

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: